SigmaMAb Trastuzumab (MSQC22) was designed to be a standard for the analysis of Trastuzumab monoclonal antibodies using mass spectrometry. An isotopically labeled version is available as SILu(TM)Mab Trastuzumab (MSQC23). SigmaMAb Trastuzumab is for R&D use only. Not for drug, household, or other...